Cell Fractionation of U937 Cells in the Absence of High-speed Centrifugation
January 18th, 2019
Here, we present a protocol to isolate the plasma membrane, cytoplasm and mitochondria of U937 cells without the use of high-speed centrifugation. This technique can be used to purify subcellular fractions for subsequent examination of protein localization via immunoblotting.
This protocol allows researchers to obtain distinct fractions of a cell without the use of specialized equipment, expensive reagents or complex techniques.The primary advantage of this protocol is the simplicity of the techniques which make it modifiable and easy to perform.Demonstrating the procedure will be Matt Deragon, Rob Haluska and Alexa Hodges.Three graduate students from my laboratory.To begin centrifuge the prepared cell suspension to create a pellet.Remove the supernatant and re-suspend the pellet in room temperature PBS.Centrifuge the cell suspension at 400 xg for ten minutes.Then remove the supernatant and re-suspend the cell pellet in ice cold buffer.Prepare buffer A solution according to the text protocol.Centrifuge the cell suspension at 400 xg for ten minutes and remove the supernatant.Re-suspend the pellet in buffer A solution to a final concentration of 200 million cells per ml, and pipette gently to break up any clumps.After this incubate the cell suspension on an end over end rotator at 4
View the full transcript and gain access to thousands of scientific videos
Overview
This article presents a protocol for isolating the plasma membrane, cytoplasm, and mitochondria of U937 cells without high-speed centrifugation. The technique allows for the purification of subcellular fractions for protein localization studies via immunoblotting.
Key Study Components
Area of Science
- Cell Biology
- Biochemistry
- Neuroscience
Background
- U937 cells are a model for studying human monocyte function.
- Isolation of subcellular components is crucial for understanding cellular processes.
- Traditional methods often involve high-speed centrifugation, which can be harsh on cells.
- This protocol aims to provide a gentler alternative for subcellular fractionation.
Purpose of Study
- To develop a protocol for isolating cell components without high-speed centrifugation.
- To enable subsequent analysis of protein localization.
- To enhance the understanding of cellular mechanisms in U937 cells.
Methods Used
- Isolation of plasma membrane, cytoplasm, and mitochondria.
- Use of specific reagents to facilitate cell fractionation.
- Immunoblotting for protein localization analysis.
- Comparison of results with traditional methods.
Main Results
- Successful isolation of subcellular fractions without high-speed centrifugation.
- Clear visualization of protein localization via immunoblotting.
- Demonstrated efficiency and gentleness of the new protocol.
- Potential for broader applications in cellular biology research.
Conclusions
- The new protocol is effective for isolating U937 cell components.
- It provides a viable alternative to traditional methods.
- Future studies can utilize this technique for various cellular analyses.
Frequently Asked Questions
Executive Industry Relevance
This protocol enables cost-effective subcellular fractionation of U937 cells without high-speed centrifugation, supporting target validation and mechanistic de-risking in early discovery. By isolating cytoplasm, mitochondria, and plasma membrane fractions using accessible reagents and equipment, it facilitates protein localization studies critical for pathway clarification and assay development. The approach reduces dependency on specialized infrastructure, enhancing scalability and reproducibility in preclinical target evaluation workflows.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through subcellular protein localization in a human monocyte model relevant to immunology and inflammation.
- Operational Value: Provides a gentler alternative to ultracentrifugation, preserving protein integrity and complex formation for functional target assessment.
- Predictive Value: Supports mechanistic de-risking by clarifying pathway involvement and compartment-specific signaling in disease-relevant cells.
Screening & Assay Development
- Assay Readiness: Generates purified subcellular fractions suitable for immunoblotting-based assays to evaluate target engagement or modulation.
- Reproducibility: Uses standardized buffer conditions and differential centrifugation steps to ensure consistent fractionation across experiments.
- Scalability: Protocol can be adjusted to accommodate varying cell numbers, supporting medium-throughput screening preparations.
Translational & Preclinical Research
- Disease Relevance: U937 cells model human monocyte function, enabling translational biomarker exploration in inflammatory and infectious disease contexts.
- Preclinical Continuity: Isolated fractions support downstream validation of target localization and mechanism of action prior to in vivo studies.
- Risk-Adjusted Advancement: Facilitates early de-risking of targets by confirming subcellular accessibility and interaction potential.
Pipeline & Workflow Integration
The method fits within the early discovery continuum, supporting target validation through biochemical fractionation before progressing to assay development and preclinical evaluation.
- Discovery Biology: Enables hypothesis testing via subcellular fractionation to clarify target localization and pathway involvement in U937 cells.
- Screening: Produces standardized cytoplasmic, mitochondrial, and membrane fractions for reliable immunoblotting-based target validation assays.
- Analytics: Generates quantitative protein localization data through immunoblotting, enabling comparison of target distribution across conditions.
- Translational Research: Supports biomarker alignment by confirming target presence in disease-relevant subcellular compartments of a human monocyte model.
- Enterprise Reuse: Establishes a reusable, low-cost fractionation capability applicable across multiple targets and projects in immunology and inflammation research.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence in target validation by reducing mechanistic ambiguity through direct subcellular localization evidence.
- Operational Value: Eliminates need for ultracentrifugation, lowering equipment costs and increasing accessibility across research sites.
- Strategic Value: Improves go/no-go decision efficiency by providing early, reliable data on target accessibility and compartmentalization.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on validated subcellular localization in a physiologically relevant human cell model.
Implementation Considerations
- Requires expertise in cell culture, subcellular fractionation, and immunoblotting techniques.
- Depends on access to refrigerated centrifuges, rotators, and standard laboratory reagents like digitonin and hypotonic buffers.
- Necessitates standardization of cell density, incubation times, and lysis conditions to ensure reproducible fractionation across users.
- Adaptation to other cell types may require optimization of lysis buffer composition and centrifugation parameters.
- Practical limitations include potential incomplete separation of organelles and variability in yield depending on cell health and passage number.
